Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Hindsight 20/20 is a Q&A feature where veterans of the medtech industry share career highlights, specific achievements and hurdles they have faced. In this installment, Kevin Brown, global VP of scientific research at radiation therapy specialist Elekta, discusses the challenges of translating scientific ideas into breakthrough technologies that bring value to clinicians and patients. He also addresses his guiding principles for picking winning ideas and his journey bringing to market the world's first integrated high-field MRI and radiotherapy system.
Medtech's biggest companies are becoming more hands-on in supporting early-stage technologies; their no longer just looking to pick up ready-to-buy assets. Among the most active in this approach is Johnson & Johnson, which has established several vehicles through which it supports and scouts external innovation. Medtech Insight chats with Mirren Mandalia, senior director of new ventures and transactions for medical devices at Johnson & Johnson Innovation, to find out what is driving J&J's technology sourcing strategy and how medtech innovators can work with the diversified health care giant.
Since selling its LifeCell aesthetic and surgical products business to Allergan in early 2017, Acelity has refocused its commercial efforts, and its name, on the KCI wound-care business, with significant investments in medical education, clinical studies and R&D in that sector, as well as the recent acquisition of UK-based Crawford Healthcare.
In the face of BD’s (Becton Dickinson & Co.) ever-broadening portfolio – bulked up by the group's appetite for billion-dollar acquisitions – the Diagnostic Systems unit remains an important, and currently the strongest, contributor to BD's overall growth story. Dave Hickey, worldwide president of BD Diagnostic Systems, spoke to Medtech Insight about the trends that are driving, as well as limiting, the in vitro diagnostics sector, and how BD is addressing those issues to keep the business's top-line buoyant.
Exec Chat: Philips' Connected Care & Health Informatics CEO On IT's Role In Tackling Health-Care Demands
The role of digital technologies in enabling health-care providers to meet rising patient demands and overcome challenges is being increasingly recognized. Yet the health-care sector continues to lag behind other industries in adopting these technologies. CEO of Philips' Connected Care & Health Informatics businesses, Carla Kriwet, tells Medtech Insight what the group has been investing in and where it is innovating to accelerate this digital revolution in health care, and how it is staying ahead of new competition from the ICT sector in this digital health game.
For many medtech companies, Asia still holds significant opportunity compared to the persistent slow growth in the more mature US and European markets. But those looking to do business in this region need to plan long term. The biggest mistake is to think you can make a quick buck, says Abel Ang, CEO of Accuron Medtech, Southeast Asia's largest medical device pure-play. The Singapore-based industry veteran shares with Medtech Insight the lessons he learned from his time building businesses for medtech multinationals in APAC and other international markets. He also gives tips from his current experience introducing a disruptive technology to this region.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.